Cargando…

Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient

Detalles Bibliográficos
Autores principales: Sagnelli, Caterina, Gentile, Valeria, Tirri, Rosella, Macera, Margherita, Cappabianca, Salvatore, Ciccia, Francesco, Coppola, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256595/
https://www.ncbi.nlm.nih.gov/pubmed/32474034
http://dx.doi.org/10.1016/j.jinf.2020.05.043
_version_ 1783539945589178368
author Sagnelli, Caterina
Gentile, Valeria
Tirri, Rosella
Macera, Margherita
Cappabianca, Salvatore
Ciccia, Francesco
Coppola, Nicola
author_facet Sagnelli, Caterina
Gentile, Valeria
Tirri, Rosella
Macera, Margherita
Cappabianca, Salvatore
Ciccia, Francesco
Coppola, Nicola
author_sort Sagnelli, Caterina
collection PubMed
description
format Online
Article
Text
id pubmed-7256595
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72565952020-05-29 Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient Sagnelli, Caterina Gentile, Valeria Tirri, Rosella Macera, Margherita Cappabianca, Salvatore Ciccia, Francesco Coppola, Nicola J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2020-12 2020-05-29 /pmc/articles/PMC7256595/ /pubmed/32474034 http://dx.doi.org/10.1016/j.jinf.2020.05.043 Text en © 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Sagnelli, Caterina
Gentile, Valeria
Tirri, Rosella
Macera, Margherita
Cappabianca, Salvatore
Ciccia, Francesco
Coppola, Nicola
Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient
title Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient
title_full Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient
title_fullStr Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient
title_full_unstemmed Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient
title_short Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient
title_sort chronic conventional disease-modifying anti-rheumatic drugs masking severe sars-cov-2 manifestations in an elderly rheumatic patient
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256595/
https://www.ncbi.nlm.nih.gov/pubmed/32474034
http://dx.doi.org/10.1016/j.jinf.2020.05.043
work_keys_str_mv AT sagnellicaterina chronicconventionaldiseasemodifyingantirheumaticdrugsmaskingseveresarscov2manifestationsinanelderlyrheumaticpatient
AT gentilevaleria chronicconventionaldiseasemodifyingantirheumaticdrugsmaskingseveresarscov2manifestationsinanelderlyrheumaticpatient
AT tirrirosella chronicconventionaldiseasemodifyingantirheumaticdrugsmaskingseveresarscov2manifestationsinanelderlyrheumaticpatient
AT maceramargherita chronicconventionaldiseasemodifyingantirheumaticdrugsmaskingseveresarscov2manifestationsinanelderlyrheumaticpatient
AT cappabiancasalvatore chronicconventionaldiseasemodifyingantirheumaticdrugsmaskingseveresarscov2manifestationsinanelderlyrheumaticpatient
AT cicciafrancesco chronicconventionaldiseasemodifyingantirheumaticdrugsmaskingseveresarscov2manifestationsinanelderlyrheumaticpatient
AT coppolanicola chronicconventionaldiseasemodifyingantirheumaticdrugsmaskingseveresarscov2manifestationsinanelderlyrheumaticpatient
AT chronicconventionaldiseasemodifyingantirheumaticdrugsmaskingseveresarscov2manifestationsinanelderlyrheumaticpatient